Browse the evidence

Exercise training blunts the acute exercise-induced activation of BCOAD in human skeletal muscle.

Regular exercise may reduce the immediate activation of BCOAD, potentially affecting BCAA metabolism.

GLP-1 receptor agonists (GLP-1RAs) are associated with accelerated facial aging and altered skin health.

Clinicians should be aware of the potential for accelerated facial aging in patients treated with GLP-1RAs.

The accelerated facial aging observed in GLP-1RA patients is multifactorial, involving loss of dermal and subcutaneous white adipose tissue.

Understanding the multifactorial nature of aging can guide treatment approaches for affected patients.

Treatment strategies targeting adipose-derived stem cell (ADSC) stimulation may mitigate facial aging effects from GLP-1RAs.

Clinicians may consider ADSC-targeted treatments to improve skin health in patients using GLP-1RAs.

Inhibition of NO synthase (NOS) reduces skeletal muscle glucose uptake during contraction.

Inhibiting NOS may impair glucose uptake during exercise, affecting performance.

The increase in skeletal muscle glucose uptake due to NO is independent of blood flow.

Understanding that NO's effect on glucose uptake is independent of blood flow can inform training strategies.

The implementation of MBSAQIP and ERAS protocols has significantly improved the quality of care for all bariatric patients.

Healthcare providers should adopt MBSAQIP and ERAS protocols to enhance patient outcomes.

Collagen supplementation did not change integrated MPS rates compared to the RDA.

Collagen may not be effective for enhancing muscle protein synthesis in older males.

Semaglutide showed a favorable hepatic safety profile with no discontinuations due to liver enzyme elevations.

Semaglutide can be considered safe for liver health in the studied population.

Higher in vivo adipose cell turnover is positively associated with BMI and VAT/TAT.

Practitioners should consider the role of adipose cell turnover in assessing metabolic health in obese individuals.

Preadipocyte and adipocyte formation is negatively associated with insulin sensitivity.

This finding suggests that higher adipocyte formation may be detrimental to insulin sensitivity, which is crucial for metabolic health.

A single-site measure of muscle shape does not adequately capture the effects of exercise training interventions.

Multiple measurement sites should be used to assess training effects accurately.

There is no significant difference in muscle hypertrophy between segments in the placebo group.

Placebo may not be effective for muscle hypertrophy in resistance training contexts.

Long-term safety monitoring of new obesity drugs is necessary due to potential serious adverse events.

Practitioners should prioritize safety monitoring for new obesity treatments.

Egg yolk intake does not further enhance muscle mass compared to egg whites in high-protein diets.

For those on high-protein diets, egg yolks may not provide additional muscle mass benefits over egg whites.

Obstructive sleep apnea is a common comorbidity in individuals with obesity.

Healthcare providers should be aware of the high prevalence of obstructive sleep apnea in obese patients.

There were no differences in antioxidant capacity markers and protein oxidation adducts between the traditional and pyramid training groups.

Both training systems are equally effective in improving oxidative stress markers.

C-reactive protein levels decreased after one year of GLP1-RA treatment.

Monitoring C-reactive protein levels may help assess the effectiveness of GLP1-RA in IBD.

Obesity and its associated conditions significantly impact healthcare systems, life expectancy, and quality of life.

Addressing obesity is crucial for improving healthcare outcomes and quality of life.

High-dose leucine supplementation did not enhance gains in muscle strength after a 12-week resistance training program.

Practitioners should consider that leucine supplementation may not provide additional benefits for muscle strength in adequately protein-fed individuals.

There were no differences in muscle cross-sectional area (mCSA) gains between the leucine and alanine groups.

Leucine supplementation does not provide additional benefits for muscle size compared to alanine in resistance-trained individuals.

Concerns exist regarding the performance of dynamic spinal flexion exercises, such as the crunch, due to the belief that the spine has a finite number of bending cycles.

Fitness professionals should consider the potential risks associated with dynamic spinal flexion exercises in program design.

Pea protein supplementation had an intermediate, non-significant effect on muscle damage biomarkers compared to water.

Pea protein may offer some benefits for muscle recovery, but less effectively than whey protein.

Training did not elicit changes in the maximal activities of citrate synthase and malate dehydrogenase.

Short-term training may not enhance certain mitochondrial enzyme activities.